Search research articles
Contact Us
Filters
Showing results (51-60 of 68) with videos related to
Page
of 7
Sort By:
Cancer Research
|
August 15, 1987
Characterization of a new surface epitope specific for human epithelial cells defined by a monoclonal antibody and application to tumor diagnosis
J Gioanni, M Samson, E Zanghellini, et al.
The International Journal of Biological Markers
|
February 6, 2004
Prognostic value of S-phase fraction in 920 breast cancer patients: focus on T1N0 status
R Largillier, M Namer, A Ramaioli, et al.
European Radiology
|
March 21, 2008
Stereotactic vacuum biopsy of calcifications with a handheld portable biopsy system: a validation study
P Taourel, D Hoa, C Chaveron, et al.
Oncology
|
September 6, 2007
Early versus late local recurrences after conservative treatment of breast carcinoma: differences in primary tumor characteristics and patient outcome
A Courdi, R Largillier, J-M Ferrero, et al.
Journal De Radiologie
|
January 1, 1992
[Imaging of anaplastic carcinoma of the thyroid gland]
O Bittmann, J N Bruneton, D Fenart, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
December 16, 2010
[Second conservative radiosurgical treatment for ipsilateral breast cancer recurrence]
J Castelli, A Figl, I Raoust, et al.
European Journal of Cancer & Clinical Oncology
|
September 1, 1988
Two new human tumor cell lines derived from squamous cell carcinomas of the tongue: establishment, characterization and response to cytotoxic treatment
J Gioanni, J L Fischel, J C Lambert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 10, 2000
P53 determination alongside classical prognostic factors in node-negative breast cancer: an evaluation at more than 10-year follow-up
J M Ferrero, A Ramaioli, J L Formento, et al.
Biochemical and Biophysical Research Communications
|
July 25, 2014
Expression of the hypoxia-inducible monocarboxylate transporter MCT4 is increased in triple negative breast cancer and correlates independently with clinical outcome
J Doyen, C Trastour, F Ettore, et al.
British Journal of Cancer
|
October 28, 2010
Pathological complete response and survival according to the level of HER-2 amplification after trastuzumab-based neoadjuvant therapy for breast cancer
S Guiu, M Gauthier, B Coudert, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 68) with videos related to
Sort By:
Page
of 7
Cancer Research
|
August 15, 1987
Characterization of a new surface epitope specific for human epithelial cells defined by a monoclonal antibody and application to tumor diagnosis
J Gioanni, M Samson, E Zanghellini, et al.
The International Journal of Biological Markers
|
February 6, 2004
Prognostic value of S-phase fraction in 920 breast cancer patients: focus on T1N0 status
R Largillier, M Namer, A Ramaioli, et al.
European Radiology
|
March 21, 2008
Stereotactic vacuum biopsy of calcifications with a handheld portable biopsy system: a validation study
P Taourel, D Hoa, C Chaveron, et al.
Oncology
|
September 6, 2007
Early versus late local recurrences after conservative treatment of breast carcinoma: differences in primary tumor characteristics and patient outcome
A Courdi, R Largillier, J-M Ferrero, et al.
Journal De Radiologie
|
January 1, 1992
[Imaging of anaplastic carcinoma of the thyroid gland]
O Bittmann, J N Bruneton, D Fenart, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
December 16, 2010
[Second conservative radiosurgical treatment for ipsilateral breast cancer recurrence]
J Castelli, A Figl, I Raoust, et al.
European Journal of Cancer & Clinical Oncology
|
September 1, 1988
Two new human tumor cell lines derived from squamous cell carcinomas of the tongue: establishment, characterization and response to cytotoxic treatment
J Gioanni, J L Fischel, J C Lambert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 10, 2000
P53 determination alongside classical prognostic factors in node-negative breast cancer: an evaluation at more than 10-year follow-up
J M Ferrero, A Ramaioli, J L Formento, et al.
Biochemical and Biophysical Research Communications
|
July 25, 2014
Expression of the hypoxia-inducible monocarboxylate transporter MCT4 is increased in triple negative breast cancer and correlates independently with clinical outcome
J Doyen, C Trastour, F Ettore, et al.
British Journal of Cancer
|
October 28, 2010
Pathological complete response and survival according to the level of HER-2 amplification after trastuzumab-based neoadjuvant therapy for breast cancer
S Guiu, M Gauthier, B Coudert, et al.
Page
of 7